Inclusion completed

Phase I Study of Single Agent MK-3475 in Patients with Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, and Non-Small Cell Lung Carcinoma

Cancer type: Lung cancer

Phase: I

Principal Investigator: Brunsvig Paal

Country: NO

Keywords: Norway, Oslo, NSCLC, lung cancer

Status: Inclusion completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01295827?term=MK+3475-001&rank=1